awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43081790-7E5B75B1-910F-456D-9447-A3AC23DB1FF6
Q43081790-7E5B75B1-910F-456D-9447-A3AC23DB1FF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43081790-7E5B75B1-910F-456D-9447-A3AC23DB1FF6
Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24.
P2860
Q43081790-7E5B75B1-910F-456D-9447-A3AC23DB1FF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43081790-7E5B75B1-910F-456D-9447-A3AC23DB1FF6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d17d01e3484d9e333975079a750fb06637f7918
P2860
A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: a study of the Nati